Barry D. Quart

Insider Reports History

Location
Lexington, MA
Signature
/s/ Douglas Barry, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barry D. Quart:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Employee Stock Option (Right to Buy) 850K $1.51M $1.78 18 Jan 2023 Direct
Kiniksa Pharmaceuticals International, plc Director Class A Ordinary Share 12.5K $521K $41.51 15 Dec 2025 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Common Stock 178K $383K $2.15 13 Jan 2023 Direct
HERON THERAPEUTICS, INC. /DE/ Chief Executive Officer, Director Restricted Stock Units 115K $247K $2.15 13 Jan 2023 Direct
Kiniksa Pharmaceuticals International, plc Director Restricted Share Units 0 05 Jun 2025 Direct
Kiniksa Pharmaceuticals International, plc Director Share Option 0 15 Dec 2025 Direct

Insider Reports Filed by Barry D. Quart

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KNSA Kiniksa Pharmaceuticals International, plc 15 Dec 2025 3 -$627K 4 Director 17 Dec 2025, 16:38
KNSA Kiniksa Pharmaceuticals International, plc 09 Jun 2025 9 -$729K 4 Director 11 Jun 2025, 17:35
KNSA Kiniksa Pharmaceuticals International, plc 03 Jun 2025 4 $0 4 Director 05 Jun 2025, 16:53
KNSA Kiniksa Pharmaceuticals, Ltd. 05 Jun 2024 4 $0 4 Director 07 Jun 2024, 16:35
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2023 2 $0 4 Director 03 Jul 2023, 16:15
KNSA Kiniksa Pharmaceuticals, Ltd. 06 Jun 2023 2 $0 4 Director 08 Jun 2023, 16:21
HRTX HERON THERAPEUTICS, INC. /DE/ 18 Jan 2023 1 $0 4 Chief Executive Officer, Director 20 Jan 2023, 16:10
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Jan 2023 6 -$11.1K 4 Chief Executive Officer, Director 17 Jan 2023, 16:36
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Nov 2022 3 -$320K 4 Director 01 Dec 2022, 15:16
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Oct 2022 5 -$19.6K 4 Chief Executive Officer, Director 17 Oct 2022, 16:38
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Jul 2022 6 -$9.93K 4 Chief Executive Officer, Director 15 Jul 2022, 16:57
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2022 2 $0 4 Director 30 Jun 2022, 16:22
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Apr 2022 5 -$31.7K 4 Chief Executive Officer, Director 15 Apr 2022, 17:05
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Jan 2022 5 -$43.3K 4 Chief Executive Officer, Director 14 Jan 2022, 16:08
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Oct 2021 5 -$10.2K 4 Chief Executive Officer, Director 15 Oct 2021, 16:25
HRTX HERON THERAPEUTICS, INC. /DE/ 13 Jul 2021 4 $8.27K 4 Chief Executive Officer, Director 15 Jul 2021, 16:50
KNSA Kiniksa Pharmaceuticals, Ltd. 29 Jun 2021 1 $0 4 Director 30 Jun 2021, 16:20